Connor, Clark & Lunn Investment Management (CC&L)’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-32,418
Closed -$77.5K 1612
2023
Q3
$77.5K Sell
32,418
-151,102
-82% -$335K ﹤0.01% 1308
2023
Q2
$424K Sell
183,520
-128,143
-41% -$362K ﹤0.01% 1026
2023
Q1
$795K Buy
311,663
+19,707
+7% +$56.5K ﹤0.01% 775
2022
Q4
$733K Buy
+291,956
New +$815K ﹤0.01% 781

Other funds holding SLGC

Connor, Clark & Lunn Investment Management (CC&L)'s SLGC Position: Q4 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q4 2023, closing a stake of 32,418 shares — an estimated $77.5K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in SLGC in Q4 2022 and held it in 4 quarters. The position peaked at $795K in Q1 2023. 119 funds tracked by Wall St. Rank hold SLGC as of Q4 2023.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 32,418 SomaLogic, Inc. Class A Common Stock shares in Q4 2023, an estimated $77.5K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2022 and held it in 4 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s SomaLogic, Inc. Class A Common Stock position peaked at $795K in Q1 2023.
  • 119 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q4 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2023, filed 9 Feb 2024.